The New England Journal of Medicine: Acute Hemolytic Anemia Associated with Infectious Mononucleosis Monthly Prescribing Reference: Rilzabrutinib Gets Breakthrough Status for Warm Autoimmune Hemolytic Anemia Phase 2b LUMINA 2 study data support rilzabrutinib's FDA Breakthrough Therapy designation for the treatment of warm autoimmune hemolytic anemia. The Food and Drug Administration (FDA) has granted ... The New England Journal of Medicine: Acute Hemolytic Anemia in Primary Atypical Pneumonia Produced by Exposure and Chilling Acute Hemolytic Anemia in Primary Atypical Pneumonia Produced by Exposure and Chilling Yahoo Finance: Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA) "People living with warm autoimmune hemolytic anemia face a serious, life-threatening disease with no approved treatment options and a high risk of complications, including profound chronic fatigue, ...

Understanding the Context

Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA) A 47-year-old woman in Germany had spent more than a decade battling three severe autoimmune diseases at once: autoimmune hemolytic anemia (AIHA), immune thrombocytopenia (ITP), and antiphospholipid ... The American Journal of Managed Care: Management of Autoimmune Hemolytic Anemia Needs Improvement, Investigators Say Additional population-based studies of autoimmune hemolytic anemia and its management are needed to reduce mortality in this patient population. Autoimmune hemolytic anemia (AIHA) is typically a ... Mihir Raval, MD, MPH, comments on the difference between cold agglutinin disease and other autoimmune hemolytic anemias.

Key Insights

Neil Minkoff, MD: Now, you had mentioned that there are other autoimmune ... CAR T-cell therapies are now being used to treat patients with B-cell driven autoimmune diseases such as lupus. Another such condition is autoimmune hemolytic anemia, in which immune cells destroy red ... Monthly Prescribing Reference: Pyrukynd Approved for Hemolytic Anemia Due to Pyruvate Kinase Deficiency The FDA has approved Pyrukynd (mitapivat) for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. The Food and Drug Administration (FDA) has approved Pyrukynd ® (mitapivat) ...

Final Thoughts

Cold antibody hemolytic anemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells by autoantibodies at temperatures of approximately 0 to 10 degrees Celsius. Q ...